drugset / Trial / NCT00247026

The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes

NCT00247026

Phase 1/2 Withdrawn 50 enrolled Hadassah Medical Organization
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine the clinical effects of coenzyme Q10 and Curcumin in improving the cytopenias of patients with myelodysplastic syndromes. we propose to explore the efficacy of the natural compounds curcumin and CoQ10 in MDS because these two agents possess many of the effects that are desirable in MDS.

Timeline

Start
2007-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme Q10 Other / unclassified
Subject Curcumin Small molecule